[1] Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia[J]. N Engl J Med, 2004, 350: 1535-1548. [2] Hefazi M, Litzow MR. Recent advances in the biology and treatment of T cell acute lymphoblastic leukemia[J]. Curr Hematol Malig Rep, 2018, 13: 265-274. [3] Belver L, Ferrando A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia[J]. Nat Rev Cancer, 2016, 16: 494-507. [4] Sanchez-Martin M, Ferrando A. The NOTCH1-C-MYC highway toward T-cell acute lymphoblastic leukemia[J]. Blood, 2017, 129: 1124-1133. [5] Girardi T, Vicente C, Cools J, et al. The genetics and molecular biology of T-ALL[J]. Blood, 2017, 129: 1113-1123. [6] Singh A, Trivedi P, Jain NK. Advances in siRNA delivery in cancer therapy[J]. Artif Cells Nanomed Biotechnol, 2018, 46: 274-283. [7] Singh RS, Kaur N, Rana V, et al. Pullulan: a novel molecule for biomedical applications[J]. Carbohydr Polym, 2017, 171: 102-121. [8] Pegg AE. The function of spermine[J]. IUBMB Life, 2014, 66: 8-18. [9] Thakor DK, Teng YD, Tabata Y. Neuronal gene delivery by negatively charged pullulan-spermine/DNA anioplexes[J]. Biomaterials, 2009, 30: 1815-1826. [10] Thomsen LB, Lichota J, Kim KS, et al. Gene delivery by pullulan derivatives in brain capillary endothelial cells for protein secretion[J]. J Control Release, 2011, 151: 45-50. [11] Jo J, Ikai T, Okazaki A, et al. Expression profile of plasmid DNA by spermine derivatives of pullulan with different extents of spermine introduced[J]. J Control Release, 2007, 118: 389-398. [12] Ma W, Liu J, Xie J, et al. Modulating the growth and imatinib sensitivity of chronic myeloid leukemia stem/progenitor cells with pullulan/microRNA nanoparticles in vitro[J]. J Biomed Nanotechnol, 2015, 11: 1961-1974. [13] Zhang W, Liu J, Tabata Y, et al. The effect of serum in culture on RNAi efficacy through modulation of polyplexes size[J]. Biomaterials, 2014, 35: 567-577. [14] Sharma A, Vaghasiya K, Ray E, et al. Lysosomal targeting strategies for design and delivery of bioactive for therapeutic interventions[J]. J Drug Target, 2018, 26: 208-221. [15] Hajimolaali M, Mohammadian H, Torabi A, et al. Application of chloroquine as an endosomal escape enhancing agent: new frontiers for an old drug[J]. Expert Opin Drug Deliv, 2021,22: 1-13. [16] Joris F, De Backer L, Van de Vyver T, et al. Repurpos-ing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells[J]. J Control Release, 2018, 269: 266-276. |